A carregar...
The Clinical Benefits of Dutasteride Treatment for LUTS and BPH
Dutasteride is the first dual inhibitor of both 5α-reductase Types 1 and 2 isoenzymes, with efficacy and safety proven in 3 randomized placebo-controlled trials, each 2 years in duration. The current report demonstrates that longer-term treatment over 48 months with dutasteride results in continuing...
Na minha lista:
Autor principal: | |
---|---|
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
MedReviews, LLC
2004
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1472913/ https://ncbi.nlm.nih.gov/pubmed/16985921 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|